STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Legend Biotech Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for Legend Biotech Corp (LEGN) reports a proposed sale of 1,000 American Depositary Shares through Fidelity Brokerage Services with an aggregate market value of $33,285 and an approximate sale date of 09/26/2025 on NASDAQ. The shares were acquired on 06/20/2022 as restricted stock vesting from the issuer and were paid as compensation. The filing lists 367,298,315 shares outstanding for the class and discloses a prior sale by Patrick Casey of 1,000 ADS on 06/26/2025 for $33,234. The filer signs the required representation that they are unaware of material nonpublic information.

Positive
  • Full Rule 144 disclosure provided including broker, acquisition details, and prior three-month sale
  • Securities were acquired via restricted stock vesting, clearly stated as compensation
Negative
  • Insider sale occurred: prior sale of 1,000 ADS on 06/26/2025 is disclosed

Insights

TL;DR: Routine Rule 144 disclosure of an insider sale; filing documents acquisition source and recent sale, satisfying disclosure requirements.

The Form 144 provides the standard items required under Rule 144: identity of broker, number of ADS to be sold, aggregate market value, acquisition date and nature of acquisition, and a prior sale within the three-month lookback period. The filing explicitly states the shares were acquired via restricted stock vesting on 06/20/2022 and identifies the prior sale on 06/26/2025. From a compliance perspective, the document appears complete for a notice of proposed sale and includes the attestation regarding material nonpublic information. No regulatory exceptions or special conditions are disclosed in the filing.

TL;DR: Insiders disclosed a small sale of 1,000 ADS; the item is a routine liquidity event with limited apparent market impact.

The notice shows an insider intends to sell 1,000 American Depositary Shares via Fidelity with an indicated aggregate market value of $33,285. The shares were granted through restricted stock vesting and treated as compensation. The filing also records a previous sale of 1,000 ADS on 06/26/2025 for $33,234. The information supplied is factual and concise; it does not include company financials or forward-looking statements, so its informational impact on the broader investment case is limited based on the filing contents alone.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for LEGN disclose?

The filing discloses a proposed sale of 1,000 American Depositary Shares via Fidelity with an aggregate market value of $33,285 and an approximate sale date of 09/26/2025.

When and how were the shares being sold acquired?

The shares were acquired on 06/20/2022 as restricted stock vesting from the issuer and the payment nature is listed as compensation.

Is there any recent prior sale by the same person disclosed?

Yes. The filing shows Patrick Casey sold 1,000 ADS on 06/26/2025 for $33,234.

On which exchange is the proposed sale expected to occur?

The filing lists the NASDAQ as the securities exchange for the proposed sale.

How many shares outstanding does the filing list for the class?

The filing reports 367,298,315 shares outstanding for the class in the Form 144 table.
Legend Biotech Corp

NASDAQ:LEGN

LEGN Rankings

LEGN Latest News

LEGN Latest SEC Filings

LEGN Stock Data

5.73B
182.17M
1.3%
47.49%
4.26%
Biotechnology
Healthcare
Link
United States
Somerset